Cannabis plus opioid co-dependence worsens cognitive impairment beyond opioids alone

People with combined opioid and cannabis dependence showed worse executive function and working memory deficits than those with opioid dependence alone, particularly in category completion and error patterns.

Ghosh, Abhishek et al.·Journal of psychoactive drugs·2025·Moderate EvidenceCross-Sectional
RTHC-06537Cross SectionalModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Cross-Sectional
Evidence
Moderate Evidence
Sample
N=496

What This Study Found

The OD+CD group completed significantly fewer categories on the Wisconsin Card Sorting Test than healthy controls and had more non-perseverative errors. Both OD and OD+CD groups showed verbal working memory deficits. Interestingly, the OD+CU (cannabis use without dependence) group performed better than controls on one trail-making measure.

Key Numbers

496 participants (97.5% men). OD+CD: fewer WCST categories completed, more non-perseverative errors than HC. OD and OD+CD: more verbal working memory 2-back errors than HC. OD+CU: fewer TMT-B errors than HC.

How They Did This

Cross-sectional controlled study comparing cognitive function across 268 opioid-dependent (OD), 58 OD with cannabis use (OD+CU), 115 OD with cannabis dependence (OD+CD), and 68 healthy controls using SPM, WCST, IGT, TMT, and n-back tests.

Why This Research Matters

Cannabis is often viewed as relatively benign compared to opioids, but when combined with opioid dependence, cannabis dependence appears to add measurable cognitive burden. This has implications for treatment planning and cognitive rehabilitation.

The Bigger Picture

The unexpected finding that cannabis use (without dependence) was associated with better performance on one measure challenges simple additive models of substance-related cognitive impairment and suggests moderate cannabis use may not compound opioid-related deficits.

What This Study Doesn't Tell Us

Overwhelmingly male sample (97.5%). Cross-sectional design cannot determine if cognitive deficits preceded or resulted from substance use. Cannabis use versus dependence distinction is clinical, not biological.

Questions This Raises

  • ?Why did cannabis use (without dependence) appear protective on trail-making performance?
  • ?Do the additive cognitive deficits of cannabis+opioid dependence reverse with dual abstinence?

Trust & Context

Key Stat:
cannabis dependence combined with opioid dependence produced worse executive function than opioid dependence alone
Evidence Grade:
Reasonable sample sizes with appropriate controls and validated neuropsychological tests, but cross-sectional design and overwhelmingly male sample limit generalizability.
Study Age:
2025 publication.
Original Title:
Neurocognitive Dysfunctions in People with Concurrent Cannabis Use and Opioid Dependence: A Cross-Sectional, Controlled Study.
Published In:
Journal of psychoactive drugs, 57(1), 71-83 (2025)
Database ID:
RTHC-06537

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

A snapshot of a population at one point in time.

What do these levels mean? →

Frequently Asked Questions

Does cannabis make opioid-related cognitive problems worse?

Cannabis dependence (not just use) appeared to worsen specific cognitive deficits when combined with opioid dependence, particularly executive function measured by category completion. However, cannabis use without dependence did not show the same pattern.

Why did cannabis users without dependence perform better on one test?

The finding was unexpected and could reflect selection bias (more functional users), or potentially some cognitive benefits of moderate cannabis use. It requires replication before drawing conclusions.

Read More on RethinkTHC

Cite This Study

RTHC-06537·https://rethinkthc.com/research/RTHC-06537

APA

Ghosh, Abhishek; Shaktan, Alka; Verma, Abhishek; Basu, Debasish; Rana, Devender K; Nehra, Ritu; Ahuja, Chirag K; Modi, Manish; Singh, Paramjit. (2025). Neurocognitive Dysfunctions in People with Concurrent Cannabis Use and Opioid Dependence: A Cross-Sectional, Controlled Study.. Journal of psychoactive drugs, 57(1), 71-83. https://doi.org/10.1080/02791072.2024.2308213

MLA

Ghosh, Abhishek, et al. "Neurocognitive Dysfunctions in People with Concurrent Cannabis Use and Opioid Dependence: A Cross-Sectional, Controlled Study.." Journal of psychoactive drugs, 2025. https://doi.org/10.1080/02791072.2024.2308213

RethinkTHC

RethinkTHC Research Database. "Neurocognitive Dysfunctions in People with Concurrent Cannab..." RTHC-06537. Retrieved from https://rethinkthc.com/research/ghosh-2025-neurocognitive-dysfunctions-in-people

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.